Zyloprim Oral Tablet 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Zyloprim: Oral tablet (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_5953.JPG
Allopurinol 100mg Tab
Actavis Inc. formerly Watson Pharmaceuticals Inc
Pill Identification: DAN DAN  |  5543
Drug Image file DrugItem_5951.JPG
Allopurinol 100mg Tab
Major Pharmaceuticals Inc
Pill Identification: MP 71 
Drug Image file DrugItem_7261.JPG
Zyloprim 100mg Tab
Prometheus Laboratories Inc
Pill Identification: ZYLOPRIM 100 
Drug Image file DrugItem_2706.JPG
Allopurinol 100mg Tab
Mylan Institutional LLC formerly UDL Laboratories Inc
Pill Identification: M 31 
Drug Image file DrugItem_3088.JPG
Allopurinol 100mg Tab
United Research Laboratories, Inc. a subsidiary of Sun Pharmaceutical Industries, Inc.
Pill Identification: MP 71 
Drug Image file DrugItem_9784.JPG
Allopurinol 100mg Tab
Apotex Corp
Pill Identification: APO  |  ALL 100
Drug Image file DrugItem_11483.JPG
Allopurinol 100mg Tab
Northstar Rx LLC
Pill Identification: N020 
Drug Image file DrugItem_5952.JPG
Allopurinol 100mg Tab
Sun Pharmaceutical Industries, Inc.
Pill Identification: MP 71 
Drug Image file DrugItem_13029.JPG
Allopurinol 100mg Tab
American Health Packaging
Pill Identification: DAN DAN  |  5543
Drug Image file DrugItem_1898.JPG
Allopurinol 100mg Tab
Mylan Pharmaceuticals Inc
Pill Identification: M 31 
Drug Image file DrugItem_11353.JPG
Allopurinol 100mg Tab
PD-RX Pharmaceuticals Incorporated
Pill Identification: 2083 V 
Drug Image file DrugItem_2479.JPG
Allopurinol 100mg Tab
Qualitest Pharmaceuticals Inc
Pill Identification: 2083 V 

What is this Medicine?

ALLOPURINOL (al oh PURE i nole) reduces the amount of uric acid the body makes. It is used to treat the symptoms of gout. It is also used to treat or prevent high uric acid levels that occur as a result of certain types of chemotherapy. This medicine may also help patients who frequently have kidney stones.

In-Depth Information

Zyloprim 100mg Tablet

NDC: 654830991
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Nephrolithiasis, Uric Acid Nephropathy, Renal Calculus, Hyperuricemia, Gout

Storage Information
Store in a dry place
Store between 59 to 77 degrees F
Zyloprim 100mg Tablet
Drug Image file DrugItem_7261.JPG
Prometheus Laboratories Inc
Pill Identification: ZYLOPRIM 100 
Shape: round
Color: white

Reported Side Effects for Zyloprim 100mg Tablet

Dystonic Reaction Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Metallic Taste Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Diaphoresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Conjunctivitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Chills Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Blistery Rash Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Breathing Difficulties Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Decreased Breathing Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Loss Of Memory Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Excessive Water Intake Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<1.2%*
Severity: MILD
Onset: EARLY
Inflamed Blood Vessels Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Blood In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Fats Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Sodium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Volume Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Electrolyte Imbalance Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High White Blood Cells Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Disease Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Nerve Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Brain Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Tumor Lysis Syndrome (TLS) Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Feeling Sick Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Muscle Paralysis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Rapid Muscle Twitches Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Onycholysis Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Pancytopenia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Irritated Blood Vessels Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Bruises Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Kidney Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Not Breathing Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Rhinitis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Removal Of Spleen Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Breathing Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Rash Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
<1.3%*
Severity: MILD
Onset: EARLY
Bruise Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Eosinophilia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Glycosuria Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Gynecomastia Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Death Of Liver Tissue Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Enlarged Liver Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Muscle Tone Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Decreased Sexual Desire Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Enlarged Lymph Nodes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Lymphocytes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Potassium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Calcium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Uric Acid Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
High Phosphate Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Potassium Level Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Calcium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hemolytic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Heart Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Inflamed Stomach Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Exfoliative Dermatitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Acute Lung Injury Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Distressed Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Lazy Eye Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Aplastic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Joint Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Slow Heart Beat Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Suddenly Stopped Heart Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Constipation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Disseminated Intravascular Coagulation (DIC) Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Drowsiness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Nose Bleed Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Blood Clot In Lung Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Mouth Ulcers Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Rapid Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Balance Problems Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
No White Blood Cells Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Cataracts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Intestinal Bleeding Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Intestinal Blockage Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Magnesium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Infertility Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Inflamed Iris (Eye) Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Electrolyte Imbalance Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Inflamed Nerve Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Urination Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Inflamed Optic Nerve Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Heart Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Sore Throat Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Rectal Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Protein In The Urine Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Zyloprim

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5